cobas® h 232 POC system

IVD For in vitro diagnostic use.
cobas h 232


Ordering Information

Technical Documents

The cobas h 232 POC system is a portable point-of-care system that supports optimised management of patients with symptoms of chest pain and breathlessness by allowing confident on-the-spot decision diagnosis and assessment based on laboratory comparable results5.


The cobas h 232 POC system can allow rapid and easy determination of NT-proBNP, D-Dimer and Troponin T in different settings including Community Diagnostic Centres, GP practices, ambulances and emergency rooms.

cobas h 232


  •  On-the-spot results are available in 3 steps and 12 minutes or less1,2,3


  • Handheld point of care system is lightweight and easy to use, even in mobile situation6,4


  • Wireless technology ensures immediate availability of results at all Points of Care using the cobas® infinity POC solution4


  • Accurate results, aligned with Roche central laboratory tests5


  • Operator ID entry and lockout to ensure use by authorised staff 
  • Patient and user ID to ensure correct documentation of test results
  • Quality control lockout

Control and traceability

  • Enhanced connectivity through wireless technology and a unique QR code feature can minimise errors, increase safety and streamline workflow
  • Connection to the cobas® infinity POC solution allows extension of the testing network and ensures control of operators and quality assurance from the central laboratory 
  • Automatic recertification of operators through cobas academy to ensure use by trained operators only

Available tests

View Full Table

Available tests

Test Measuring range Time to result Material number Clinical utility
40 –  2,000 ng/L
12 min
Roche CARDIAC POC Trop T (07007302190)

Early aid in diagnosis of acute myocardial infarction and identification of patients with an elevated mortality risk (1,6,7)

60 –  9,000 pg/mL
12 min
Roche CARDIAC proBNP+ (05533643190) Aid in diagnosis of patients with suspected heart failure, in monitoring of patients with compensated left ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes (2,8)
0.1 - 4.0 µg/mL
8 min Roche CARDIAC D-Dimer (04877802190) Aid in exclusion of deep venousthrombosis (3, 9) 


  1. Roche Cardiac POC Troponin T Method Sheet V 3.0 (2019)
  2. Roche Cardiac pro-BNP+ Method Sheet V 5.0 (2021)
  3. Roche Cardiac D-Dimer Method Sheet V 6.0 (2021)
  4. Roche cobas h 232 POC system Operator's Manual V 6.0 (2016)
  5. Bertsch T et al. (2010). Clin Lab 56: 37-49.
  6. Collet, J. et al. (2020). Eur Heart J 42(14), 1289-1367.
  7. Stengaard, C. et al. (2013). American J Cardiol 112(9), 1361-1366.
  8. McDonagh, T. et al. (2021). Eur J Heart 42(36), 3599-3726.
  9. NICE [NG158] Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2020) Accessed January 2023
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later